Economical and Easily Detectable Markers of Digestive Tumors: Platelet Parameters
Overview
General Medicine
Authors
Affiliations
This study aimed to evaluate the clinical values of platelet parameters in patients with digestive tumors. A total of 974 people were classified into three groups: malignant group, patients with digestive malignant tumors; benign group, patients with benign tumors; and normal group: healthy individuals. Compared with the benign and normal groups, the malignant group showed significantly increased platelet count (PLT) and plateletcrit (PCT) and significantly reduced mean platelet volume (MPV) and platelet-large cell rate (P-LCR, p < 0.001). Elevated PLT and PCT and reduced MPV and P-LCR indicated poor overall survival in patients with digestive tumors. PLT, PCT, MPV and P-LCR were proven to be predictive biomarkers for patients with digestive malignant tumors. Elevated PLT and PCT or decreased MPV and P-LCR indicated poor overall survival.
Xu B, Zhang Y, Chen G, Feng J, Gan L Front Immunol. 2022; 13:1041356.
PMID: 36466904 PMC: 9716279. DOI: 10.3389/fimmu.2022.1041356.
Awadh N, Gorial F, Hammadi R, Ibrahim M, Majeed S, Mohammed M Reumatologia. 2022; 60(3):173-182.
PMID: 35875718 PMC: 9301666. DOI: 10.5114/reum.2022.117837.
Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.
Hu L, Liu J, Shimada H, Ito M, Sugimoto K, Hiwasa T Front Oncol. 2022; 12:870086.
PMID: 35656505 PMC: 9152111. DOI: 10.3389/fonc.2022.870086.